Skip to main content

Advertisement

Table 3 Prevalence of metabolic syndrome according to four definitions and its components in pregnant women

From: Prevalence of metabolic syndrome in non-diabetic, pregnant Angolan women according to four diagnostic criteria and its effects on adverse perinatal outcomes

Components of MetS NCEPT–ATP III [5] N = 675 JIS MetS Criteria [6] N = 675 NCEPT–ATP III Bartha [10] modification N = 675 NHLBI/AHA Chatzi [8, 9] modification N = 675
Cut points N (%) Cut points N (%) Cut points N (%) Cut points N (%)
Fasting glycemia mean ≥110 mg/dl 70 (10.4) ≥100 mg/dl 124 (18.4) ≥105 mg/dl 90 (13.3) ≥100 mg/dl 124 (18.4)
Obesity    
 BMI    >30 kg/m2 75 (11.1) >30 kg/m2 75 (11.1)
 Waist circumference >88 cm 497 (73.6) ≥80 cm 657 (97.3)   _
Hypertriglyceridemia ≥150 mg/dl 293 (43.4) ≥150 mg/dl 293 (43.4) ≥270 mg/dl 15 (2.2) ≥150 mg/dl 293 (43.4)
Decreased HDL-C <50 mg/dl 53 (7.8) <50 mg/dl 53 (7.9) <40 mg/dl 17 (2.5) <50 mg/dl 53 (7.9)
Hypertension ≥130/85 mm/Hg 370 (54.8) ≥130/85 mm/Hg 370 (54.8) ≥ 130/85 mm/Hg 370 (54.8) ≥ 130/85 mm/Hg 370 (54.8)
MetS prevalence   197 (29.2)   247 (36.6)   12 (1.8)   85 (12.6)
  1. * Differences of the test proporcções—p < 0.0001 (a, b, c and d)